Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Planning and revising the sample size for a trial

A L Gould1

  • 1Merck Research Laboratories, West Point, PA 19486, USA.

Statistics in Medicine
|May 15, 1995
PubMed
Summary

Determining clinical trial sample size requires estimating variation. New methods estimate this crucial measure before and during trials without unblinding data, preserving statistical power and accuracy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strain-level diversity of symbiont communities between individuals and populations of a bioluminescent fish.

The ISME journal·2023
Same author

Chromosome-Level Genome Assembly of the Bioluminescent Cardinalfish Siphamia tubifer: An Emerging Model for Symbiosis Research.

Genome biology and evolution·2022
Same author

Life history of the symbiotically luminous cardinalfish Siphamia tubifer (Perciformes: Apogonidae).

Journal of fish biology·2016
Same author

Segregation effects on the properties of (AuAg)₁₄₇.

Physical chemistry chemical physics : PCCP·2014
Same author

Symbiosis initiation in the bacterially luminous sea urchin cardinalfish Siphamia versicolor.

Journal of fish biology·2012
Same author

Baseline differences in A1C explain apparent differences in efficacy of sitagliptin, rosiglitazone and pioglitazone.

Diabetes, obesity & metabolism·2009

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Methods

Background:

  • Accurate sample size calculation is critical for clinical trial validity.
  • Estimating the measure of variation for the key response is essential but challenging as its true value is unknown.
  • Existing methods for estimating variation, such as internal pilot studies, often require unblinding treatment assignments.

Purpose of the Study:

  • To present novel approaches for determining the measure of variation for sample size calculations.
  • To provide methods applicable both before a trial commences and after it has started.
  • To ensure these methods do not compromise statistical power or the type I error rate.

Main Methods:

  • The study describes methods to estimate the measure of variation (overall response rate or residual variance) without unblinding treatment assignments.
  • These approaches are designed for use in calculating the final sample size for clinical trials.
  • The methods are applicable to various study designs, including longitudinal studies and group sequential trials.

Main Results:

  • The proposed approaches allow for appropriate estimation of the measure of variation.
  • These methods successfully preserve the statistical power of the trial.
  • The type I error rate is not materially affected by these estimation techniques.

Conclusions:

  • Novel methods for estimating the measure of variation enable accurate sample size determination in clinical trials.
  • These techniques offer an advantage over traditional internal pilot methods by avoiding data unblinding.
  • The described approaches are versatile and can be applied to diverse clinical study designs, enhancing trial planning and execution.

Related Experiment Videos